CDEK
← All drugs Report issue

regn3500

mAbexperimental

Clinical trial activity

15 trials · 2 clinical orgs · 0 marketing orgs

Phase 1
4
Phase 2
11
Phase 3
5
Phase 4
0

Earliest trial started Aug 1, 2016 (NCT02958436)

Timeline

2010s

  1. Jan 1, 2016

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2018

    Earliest Phase 2 Sponsor(trial)

2020s

  1. Jan 1, 2020

    Earliest Phase 3 Sponsor(trial)

Indications

Studied for

Mechanism of action

Chemistry & pharmacology

Multi-specific
No

Oral

No

Parenteral

No

Topical

No

Also known as

  • regn3500

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06834347Phase 3Feb 12, 2025Regeneron, Sanofi
NCT06834360Phase 3Feb 6, 2025Regeneron, Sanofi
NCT06691113Phase 2Nov 18, 2024Regeneron, Sanofi
NCT06280391Phase 2Feb 20, 2024Regeneron, Sanofi
NCT06208306Phase 3Jan 11, 2024Regeneron, Sanofi
NCT05326412Phase 2May 19, 2022Regeneron, Sanofi
NCT06114238Phase 1Sep 16, 2021Sanofi
NCT04751487Phase 3Feb 12, 2021Regeneron, Sanofi
NCT04701983Phase 3Dec 16, 2020Regeneron, Sanofi
NCT03738423Phase 2Nov 13, 2018Regeneron, Sanofi
NCT03736967Phase 2Nov 12, 2018Regeneron, Sanofi
NCT03387852Phase 2Mar 12, 2018Regeneron, Sanofi
NCT03112577Phase 1Apr 1, 2017Regeneron, Sanofi
NCT02999711Phase 1Jan 1, 2017Regeneron, Sanofi
NCT02958436Phase 1Aug 1, 2016Regeneron, Sanofi
Showing 15 of 15 trials
Page 1 / 1

Organizations

Research & Development (2)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
SanofiFor profit151032016
RegeneronFor profit14532016
2 organizations
Page 1 / 1